| Year |
Citation |
Score |
| 2024 |
Guadalupi L, Vanni V, Balletta S, Caioli S, De Vito F, Fresegna D, Sanna K, Nencini M, Donninelli G, Volpe E, Mariani F, Battistini L, Stampanoni Bassi M, Gilio L, Bruno A, ... ... Centonze D, et al. Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. Journal of Neuroinflammation. 21: 128. PMID 38745307 DOI: 10.1186/s12974-024-03120-9 |
0.304 |
|
| 2024 |
Guadalupi L, Mandolesi G, Vanni V, Balletta S, Caioli S, Pavlovic A, De Vito F, Fresegna D, Sanna K, Vitiello L, Nencini M, Tartacca A, Mariani F, Rovella V, Schippling S, ... ... Centonze D, et al. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis. Neuropharmacology. 109940. PMID 38570068 DOI: 10.1016/j.neuropharm.2024.109940 |
0.316 |
|
| 2022 |
Stampanoni Bassi M, Iezzi E, Centonze D. Multiple sclerosis: Inflammation, autoimmunity and plasticity. Handbook of Clinical Neurology. 184: 457-470. PMID 35034754 DOI: 10.1016/B978-0-12-819410-2.00024-2 |
0.339 |
|
| 2020 |
Ziccardi L, Barbano L, Boffa L, Albanese M, Grzybowski A, Centonze D, Parisi V. Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis. Frontiers in Neurology. 11: 858. PMID 33041959 DOI: 10.3389/Fneur.2020.00858 |
0.351 |
|
| 2020 |
Stampanoni Bassi M, Buttari F, Gilio L, De Paolis N, Fresegna D, Centonze D, Iezzi E. Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective. Frontiers in Neurology. 11: 566. PMID 32733354 DOI: 10.3389/Fneur.2020.00566 |
0.428 |
|
| 2020 |
Chisari CG, Solaro C, Annunziata P, Bergamaschi R, Bianco A, Bonavita S, Brescia Morra V, Bruno Bossio R, Capello E, Castelli L, Cavalla P, Costantino G, Centonze D, Cottone S, Danni MC, et al. Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32661083 DOI: 10.1136/Jnnp-2019-322480 |
0.326 |
|
| 2020 |
Bruno A, Dolcetti E, Rizzo FR, Fresegna D, Musella A, Gentile A, De Vito F, Caioli S, Guadalupi L, Bullitta S, Vanni V, Balletta S, Sanna K, Buttari F, Stampanoni Bassi M, ... Centonze D, et al. Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14: 169. PMID 32655374 DOI: 10.3389/Fncel.2020.00169 |
0.378 |
|
| 2020 |
Stampanoni Bassi M, Iezzi E, Drulovic J, Pekmezovic T, Gilio L, Furlan R, Finardi A, Marfia GA, Sica F, Centonze D, Buttari F. IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14: 120. PMID 32655367 DOI: 10.3389/Fncel.2020.00120 |
0.374 |
|
| 2020 |
Sørensen PS, Centonze D, Giovannoni G, Montalban X, Selchen D, Vermersch P, Wiendl H, Yamout B, Salloukh H, Rieckmann P. Expert opinion on the use of cladribine tablets in clinical practice. Therapeutic Advances in Neurological Disorders. 13: 1756286420935019. PMID 32636933 DOI: 10.1177/1756286420935019 |
0.314 |
|
| 2020 |
Farini D, Cesari E, Weatheritt RJ, La Sala G, Naro C, Pagliarini V, Bonvissuto D, Medici V, Guerra M, Di Pietro C, Rizzo FR, Musella A, Carola V, Centonze D, Blencowe BJ, et al. A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum. Cell Reports. 31: 107703. PMID 32492419 DOI: 10.1016/J.Celrep.2020.107703 |
0.324 |
|
| 2020 |
Musella A, Gentile A, Guadalupi L, Rizzo FR, De Vito F, Fresegna D, Bruno A, Dolcetti E, Vanni V, Vitiello L, Bullitta S, Sanna K, Caioli S, Balletta S, Nencini M, ... ... Centonze D, et al. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis. Cells. 9. PMID 32455907 DOI: 10.3390/Cells9051290 |
0.411 |
|
| 2020 |
Patti F, Chisari CG, D'Amico E, Annovazzi P, Banfi P, Bergamaschi R, Clerici R, Conti MZ, Cortese A, Fantozzi R, Fischetti M, Frigo M, Gatto M, Immovilli P, Leoni S, ... ... Centonze D, et al. Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). Multiple Sclerosis and Related Disorders. 42: 102124. PMID 32353755 DOI: 10.1016/J.Msard.2020.102124 |
0.371 |
|
| 2020 |
Centonze D, Leocani L, Feys P. Advances in physical rehabilitation of multiple sclerosis. Current Opinion in Neurology. 33: 255-261. PMID 32304436 DOI: 10.1097/Wco.0000000000000816 |
0.344 |
|
| 2020 |
Dalgas U, Hvid LG, Kwakkel G, Motl RW, de Groot V, Feys P, Op't Eijnde B, Coote S, Beckerman H, Pfeifer K, Streber R, Peters S, Riemann-Lorenz K, Rosenkranz SC, Centonze D, et al. Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520910360. PMID 32162578 DOI: 10.1177/1352458520910360 |
0.335 |
|
| 2020 |
Musella A, Fresegna D, Rizzo FR, Gentile A, De Vito F, Caioli S, Guadalupi L, Bruno A, Dolcetti E, Buttari F, Bullitta S, Vanni V, Centonze D, Mandolesi G. 'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting. Expert Opinion On Therapeutic Targets. 1-10. PMID 31899994 DOI: 10.1080/14728222.2020.1709823 |
0.349 |
|
| 2019 |
Stampanoni Bassi M, Iezzi E, Pavone L, Mandolesi G, Musella A, Gentile A, Gilio L, Centonze D, Buttari F. Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity. International Journal of Molecular Sciences. 21. PMID 31878257 DOI: 10.3390/Ijms21010143 |
0.4 |
|
| 2019 |
Stampanoni Bassi M, Buttari F, Maffei P, Paolis N, Sancesario A, Gilio L, Pavone L, Pasqua G, Simonelli I, Sica F, Fantozzi R, Bellantonio P, Centonze D, Iezzi E. Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 31818686 DOI: 10.1016/J.Clinph.2019.10.023 |
0.381 |
|
| 2019 |
Kooij G, Derada Troletti C, Leuti A, Norris PC, Riley I, Albanese M, Ruggieri S, Libreros S, van der Pol SMA, van Het Hof B, Schell Y, Guerrera G, Buttari F, Mercuri NB, Centonze D, et al. Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction. Haematologica. PMID 31780628 DOI: 10.3324/Haematol.2019.219519 |
0.373 |
|
| 2019 |
Sica F, Centonze D, Buttari F. Fingolimod Immune Effects Beyond Its Sequestration Ability. Neurology and Therapy. 8: 231-240. PMID 31696392 DOI: 10.1007/S40120-019-00162-7 |
0.309 |
|
| 2019 |
Nicoletti CG, Landi D, Monteleone F, Mataluni G, Albanese M, Lauretti B, Rocchi C, Simonelli I, Boffa L, Buttari F, Mercuri NB, Centonze D, Marfia GA. Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis. Cns Drugs. PMID 31650471 DOI: 10.1007/S40263-019-00676-6 |
0.389 |
|
| 2019 |
Gentile A, Musella A, De Vito F, Rizzo FR, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G. Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis. Frontiers in Immunology. 10: 2197. PMID 31572399 DOI: 10.3389/Fimmu.2019.02197 |
0.357 |
|
| 2019 |
Oreja-Guevara C, Potra S, Bauer B, Centonze D, Giambastiani MP, Giovannoni G, Kesselring J, Langdon D, Morrow SA, Nouvet-Gire J, Pontaga M, Rieckmann P, Schippling S, Alexandri N, Shanahan J, et al. Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care. Advances in Therapy. PMID 31487006 DOI: 10.1007/S12325-019-01071-9 |
0.316 |
|
| 2019 |
Restivo DA, Alfonsi E, Casabona A, Hamdy S, Tassorelli C, Panebianco M, Marchese-Ragona R, Quartarone A, Centonze D, Pavone A, Bassi MS. Corrigendum to 'A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis' [Clin. Neurophysiol. 130 (2019) 1017-1024]. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 130: 2013. PMID 31473144 DOI: 10.1016/J.Clinph.2019.08.004 |
0.306 |
|
| 2019 |
Leocani L, Chieffo R, Gentile A, Centonze D. Beyond rehabilitation in MS: Insights from non-invasive brain stimulation. Multiple Sclerosis (Houndmills, Basingstoke, England). 25: 1363-1371. PMID 31469356 DOI: 10.1177/1352458519865734 |
0.369 |
|
| 2019 |
Colamatteo A, Maggioli E, Azevedo Loiola R, Hamid Sheikh M, Calì G, Bruzzese D, Maniscalco GT, Centonze D, Buttari F, Lanzillo R, Perna F, Zuccarelli B, Mottola M, Cassano S, Galgani M, et al. Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients. Journal of Immunology (Baltimore, Md. : 1950). PMID 31462505 DOI: 10.4049/Jimmunol.1801683 |
0.372 |
|
| 2019 |
Stampanoni Bassi M, Iezzi E, Mori F, Simonelli I, Gilio L, Buttari F, Sica F, De Paolis N, Mandolesi G, Musella A, De Vito F, Dolcetti E, Bruno A, Furlan R, Finardi A, ... ... Centonze D, et al. Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis. Neurorehabilitation and Neural Repair. 1545968319868713. PMID 31431121 DOI: 10.1177/1545968319868713 |
0.411 |
|
| 2019 |
Grimaldi AE, De Giglio L, Haggiag S, Bianco A, Cortese A, Crisafulli SG, Monteleone F, Marfia G, Prosperini L, Galgani S, Mirabella M, Centonze D, Pozzilli C, Castelli L. The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray). Plos One. 14: e0219670. PMID 31361750 DOI: 10.1371/Journal.Pone.0219670 |
0.363 |
|
| 2019 |
Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, Buttari F, Fantozzi R, Thomas A, Onofrj M, Centonze D, Miscia S, Marchisio M. The Characterization of Regulatory T-Cell Profiles in Alzheimer's Disease and Multiple Sclerosis. Scientific Reports. 9: 8788. PMID 31217537 DOI: 10.1038/S41598-019-45433-3 |
0.31 |
|
| 2019 |
Capone A, Bianco M, Ruocco G, De Bardi M, Battistini L, Ruggieri S, Gasperini C, Centonze D, Sette C, Volpe E. Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients. Cells. 8. PMID 31167379 DOI: 10.3390/Cells8060533 |
0.363 |
|
| 2019 |
Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Micillo T, De Rosa V, Sica F, Furlan R, Finardi A, Fantozzi R, Storto M, Bellantonio P, Pirollo P, ... ... Centonze D, et al. Obesity worsens central inflammation and disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519853473. PMID 31161863 DOI: 10.1177/1352458519853473 |
0.347 |
|
| 2019 |
Ciccocioppo F, Lanuti P, Centonze D, Miscia S, Marchisio M. The Link Among Neurological Diseases: Extracellular Vesicles as a Possible Brain Injury Footprint. Neuro-Signals. 27: 25-39. PMID 31150575 DOI: 10.33594/000000116 |
0.323 |
|
| 2019 |
Gambardella S, Limanaqi F, Ferese R, Biagioni F, Campopiano R, Centonze D, Fornai F. ccf-mtDNA as a Potential Link Between the Brain and Immune System in Neuro-Immunological Disorders. Frontiers in Immunology. 10: 1064. PMID 31143191 DOI: 10.3389/Fimmu.2019.01064 |
0.319 |
|
| 2019 |
Gentile A, De Vito F, Fresegna D, Rizzo FR, Bullitta S, Guadalupi L, Vanni V, Buttari F, Stampanoni Bassi M, Leuti A, Chiurchiù V, Marfia GA, Mandolesi G, Centonze D, Musella A. Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons. Neuropathology and Applied Neurobiology. PMID 31125471 DOI: 10.1111/Nan.12569 |
0.411 |
|
| 2019 |
Mandolesi G, Bullitta S, Fresegna D, De Vito F, Rizzo FR, Musella A, Guadalupi L, Vanni V, Stampanoni Bassi M, Buttari F, Viscomi MT, Centonze D, Gentile A. Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination. Neurobiology of Disease. 129: 102-117. PMID 31100354 DOI: 10.1016/J.Nbd.2019.05.010 |
0.356 |
|
| 2019 |
Restivo DA, Alfonsi E, Casabona A, Hamdy S, Tassorelli C, Panebianco M, Marchese-Ragona R, Quartarone A, Centonze D, Pavone A, Stampanoni Bassi M. A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 130: 1017-1024. PMID 31009904 DOI: 10.1016/J.Clinph.2019.04.003 |
0.338 |
|
| 2019 |
Stampanoni Bassi M, Gentile A, Iezzi E, Zagaglia S, Musella A, Simonelli I, Gilio L, Furlan R, Finardi A, Marfia GA, Guadalupi L, Bullitta S, Mandolesi G, Centonze D, Buttari F. Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis. Frontiers in Neurology. 10: 30. PMID 30761069 DOI: 10.3389/Fneur.2019.00030 |
0.392 |
|
| 2019 |
Nicoletti CG, Monteleone F, Marfia GA, Usiello A, Buttari F, Centonze D, Mori F. Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519828294. PMID 30730244 DOI: 10.1177/1352458519828294 |
0.425 |
|
| 2019 |
Vigo T, La Rocca C, Faicchia D, Procaccini C, Ruggieri M, Salvetti M, Centonze D, Matarese G, Uccelli A. IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism. Cell Death & Disease. 10: 85. PMID 30692524 DOI: 10.1038/S41419-019-1336-4 |
0.352 |
|
| 2019 |
Ruggieri S, Ianniello A, Giglio LD, Altieri M, Centonze D, Copetti M, Cortese A, Fantozzi R, Galgani S, Gasperini C, Grimaldi L, Landi D, Marfia GA, Mirabella M, Nistri R, et al. Different regimen of natalizumab treatment in multiple sclerosis patients: A real world study in Italy Journal of the Neurological Sciences. 405: 338-339. DOI: 10.1016/J.Jns.2019.10.1467 |
0.318 |
|
| 2018 |
Papetti L, Figà Talamanca L, Spalice A, Vigevano F, Centonze D, Valeriani M. Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents. Frontiers in Neurology. 9: 1156. PMID 30697184 DOI: 10.3389/Fneur.2018.01156 |
0.349 |
|
| 2018 |
Russo C, Riccio E, Pontillo G, Cocozza S, Tedeschi E, Centonze D, Pisani A. Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family. Multiple Sclerosis and Related Disorders. 26: 164-167. PMID 30268036 DOI: 10.1016/J.Msard.2018.09.019 |
0.348 |
|
| 2018 |
Pieri M, Zenobi R, Morello M, Storto M, Buttari F, Centonze D, Bernardini S, Dessi M. Multiple Sclerosis: kFLC index values related to gender. Multiple Sclerosis and Related Disorders. 26: 58-60. PMID 30223231 DOI: 10.1016/J.Msard.2018.08.018 |
0.388 |
|
| 2018 |
Stampanoni Bassi M, Iezzi E, Landi D, Monteleone F, Gilio L, Simonelli I, Musella A, Mandolesi G, De Vito F, Furlan R, Finardi A, Marfia GA, Centonze D, Buttari F. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course. Journal of Neurology. PMID 30167879 DOI: 10.1007/S00415-018-8994-5 |
0.375 |
|
| 2018 |
Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G. Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions. Frontiers in Aging Neuroscience. 10: 238. PMID 30135651 DOI: 10.3389/Fnagi.2018.00238 |
0.381 |
|
| 2018 |
Landi D, Ragonese P, Prosperini L, Nociti V, Haggiag S, Cortese A, Fantozzi R, Pontecorvo S, Ferraro E, Buscarinu MC, Mataluni G, Monteleone F, Salvetti M, Di Battista G, Francia A, ... ... Centonze D, et al. Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29970387 DOI: 10.1136/Jnnp-2018-318468 |
0.326 |
|
| 2018 |
Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, et al. Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study. Neurology. PMID 29875218 DOI: 10.1212/Wnl.0000000000005772 |
0.382 |
|
| 2018 |
Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Mandolesi G, Centonze D, Gentile A. Tumor Necrosis Factor and Interleukin-1 Modulate Synaptic Plasticity during Neuroinflammation. Neural Plasticity. 2018: 8430123. PMID 29861718 DOI: 10.1155/2018/8430123 |
0.401 |
|
| 2018 |
Stampanoni Bassi M, Iezzi E, Marfia GA, Simonelli I, Musella A, Mandolesi G, Fresegna D, Pasqualetti P, Furlan R, Finardi A, Mataluni G, Landi D, Gilio L, Centonze D, Buttari F. Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis. Journal of Neuroinflammation. 15: 108. PMID 29655371 DOI: 10.1186/S12974-018-1150-4 |
0.399 |
|
| 2018 |
Mango D, Nisticò R, Furlan R, Finardi A, Centonze D, Mori F. PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis. Neurochemical Research. PMID 29392518 DOI: 10.1007/S11064-018-2484-0 |
0.43 |
|
| 2018 |
Gentile A, Musella A, De Vito F, Fresegna D, Bullitta S, Rizzo FR, Centonze D, Mandolesi G. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake. Journal of Neuroinflammation. 15: 5. PMID 29304807 DOI: 10.1186/S12974-017-1048-6 |
0.397 |
|
| 2017 |
Stampanoni Bassi M, Gilio L, Buttari F, Maffei P, Marfia GA, Restivo DA, Centonze D, Iezzi E. Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach. Frontiers in Neuroscience. 11: 710. PMID 29321723 DOI: 10.3389/Fnins.2017.00710 |
0.406 |
|
| 2017 |
Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, Kobelt G, Langdon D, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P, et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. Multiple Sclerosis and Related Disorders. 19: 153-160. PMID 29241142 DOI: 10.1016/J.Msard.2017.11.013 |
0.359 |
|
| 2017 |
Stampanoni Bassi M, Garofalo S, Marfia GA, Gilio L, Simonelli I, Finardi A, Furlan R, Sancesario GM, Di Giandomenico J, Storto M, Mori F, Centonze D, Iezzi E. Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis. Frontiers in Molecular Neuroscience. 10: 390. PMID 29209169 DOI: 10.3389/Fnmol.2017.00390 |
0.389 |
|
| 2017 |
Monteleone F, Nicoletti CG, Stampanoni Bassi M, Iezzi E, Buttari F, Furlan R, Finardi A, Marfia GA, Centonze D, Mori F. Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain. Journal of Neuroimmunology. PMID 29174194 DOI: 10.1016/J.Jneuroim.2017.11.012 |
0.364 |
|
| 2017 |
La Rocca C, Carbone F, De Rosa V, Colamatteo A, Galgani M, Perna F, Lanzillo R, Brescia Morra V, Orefice G, Cerillo I, Florio C, Maniscalco GT, Salvetti M, Centonze D, Uccelli A, et al. Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration. Metabolism: Clinical and Experimental. 77: 39-46. PMID 29132538 DOI: 10.1016/J.Metabol.2017.08.011 |
0.355 |
|
| 2017 |
Chiurchiù V, van der Stelt M, Centonze D, Maccarrone M. The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases. Progress in Neurobiology. PMID 29097192 DOI: 10.1016/J.Pneurobio.2017.10.007 |
0.356 |
|
| 2017 |
Ottonello M, Pellicciari L, Centonze D, Foti C, Pistarini C, Albensi C, Giordano A. The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis. Disability and Rehabilitation. 1-7. PMID 29069950 DOI: 10.1080/09638288.2017.1393699 |
0.305 |
|
| 2017 |
Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M. Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study). Journal of Neurology. PMID 29063244 DOI: 10.1007/S00415-017-8642-5 |
0.31 |
|
| 2017 |
Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, Giovannetti AM, Pareja-Gutierrez L, Calò A, Colonna I, Furlan R, Martino G, Centonze D. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology. PMID 28842450 DOI: 10.1212/Wnl.0000000000004411 |
0.341 |
|
| 2017 |
Colais P, Agabiti N, Davoli M, Buttari F, Centonze D, De Fino C, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, et al. Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy. Neuroepidemiology. 48: 171-178. PMID 28793295 DOI: 10.1159/000479515 |
0.374 |
|
| 2017 |
Musella A, Fresegna D, Rizzo FR, Gentile A, Bullitta S, De Vito F, Guadalupi L, Centonze D, Mandolesi G. A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum. Scientific Reports. 7: 7363. PMID 28779174 DOI: 10.1038/S41598-017-07519-8 |
0.366 |
|
| 2017 |
Messina S, Solaro C, Righini I, Bergamaschi R, Bonavita S, Bossio RB, Brescia Morra V, Costantino G, Cavalla P, Centonze D, Comi G, Cottone S, Danni MC, Francia A, Gajofatto A, et al. Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study). Plos One. 12: e0180651. PMID 28763462 DOI: 10.1371/Journal.Pone.0180651 |
0.323 |
|
| 2017 |
Mandolesi G, Bullitta S, Fresegna D, Gentile A, De Vito F, Dolcetti E, Rizzo FR, Strimpakos G, Centonze D, Musella A. Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum. Neurobiology of Disease. PMID 28757328 DOI: 10.1016/J.Nbd.2017.07.019 |
0.386 |
|
| 2017 |
Stampanoni Bassi M, Leocani L, Comi G, Iezzi E, Centonze D. Can pharmacological manipulation of LTP favor the effects of motor rehabilitation in multiple sclerosis? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517721358. PMID 28735565 DOI: 10.1177/1352458517721358 |
0.413 |
|
| 2017 |
Landi D, Albanese M, Buttari F, Monteleone F, Boffa L, Rossi S, Motta C, Puma E, Centonze D. Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study. Plos One. 12: e0165415. PMID 28686675 DOI: 10.1371/Journal.Pone.0165415 |
0.327 |
|
| 2017 |
Pieri M, Storto M, Pignalosa S, Zenobi R, Buttari F, Bernardini S, Centonze D, Dessi M. KFLC Index utility in multiple sclerosis diagnosis: Further confirmation. Journal of Neuroimmunology. 309: 31-33. PMID 28601282 DOI: 10.1016/J.Jneuroim.2017.05.007 |
0.323 |
|
| 2017 |
Stampanoni Bassi M, Mori F, Buttari F, Marfia GA, Sancesario A, Centonze D, Iezzi E. Neurophysiology of synaptic functioning in multiple sclerosis. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 128: 1148-1157. PMID 28511127 DOI: 10.1016/J.Clinph.2017.04.006 |
0.455 |
|
| 2017 |
Maccarrone M, Maldonado R, Casas M, Henze T, Centonze D. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? Expert Review of Clinical Pharmacology. 1-13. PMID 28276775 DOI: 10.1080/17512433.2017.1292849 |
0.335 |
|
| 2017 |
Landi D, De Rossi N, Zagaglia S, Scarpazza C, Prosperini L, Albanese M, Buttari F, Mori F, Marfia GA, Sormani MP, Capra R, Centonze D. No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML. Neurology. PMID 28228569 DOI: 10.1212/Wnl.0000000000003740 |
0.352 |
|
| 2017 |
Gallo P, Centonze D, Marrosu MG. Alemtuzumab for multiple sclerosis: the new concept of immunomodulation Multiple Sclerosis and Demyelinating Disorders. 2. DOI: 10.1186/S40893-017-0024-4 |
0.339 |
|
| 2016 |
Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Teresa Ciotti M, Hornstein E, Bozzoni I, ... ... Centonze D, et al. miR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27920149 DOI: 10.1523/Jneurosci.0851-16.2017 |
0.341 |
|
| 2016 |
Chiurchiù V, Leuti A, Cencioni MT, Albanese M, De Bardi M, Bisogno T, Centonze D, Battistini L, Maccarrone M. Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors. Pharmacological Research. PMID 27616551 DOI: 10.1016/J.Phrs.2016.09.003 |
0.385 |
|
| 2016 |
Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F, Fantozzi R, Usiello A, Maccarrone M, Mercuri NB, Lutz B, Mandolesi G, Centonze D. Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 13: 231. PMID 27589957 DOI: 10.1186/S12974-016-0682-8 |
0.375 |
|
| 2016 |
Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. Journal of Neuroinflammation. 13: 207. PMID 27566665 DOI: 10.1186/S12974-016-0686-4 |
0.449 |
|
| 2016 |
Feys P, Giovannoni G, Dijsselbloem N, Centonze D, Eelen P, Lykke Andersen S. The importance of a multi-disciplinary perspective and patient activation programmes in MS management. Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 34-46. PMID 27465614 DOI: 10.1177/1352458516650741 |
0.358 |
|
| 2016 |
Patti F, Messina S, Solaro C, Amato MP, Bergamaschi R, Bonavita S, Bruno Bossio R, Brescia Morra V, Costantino GF, Cavalla P, Centonze D, Comi G, Cottone S, Danni M, Francia A, et al. Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27160523 DOI: 10.1136/Jnnp-2015-312591 |
0.355 |
|
| 2016 |
Catanzaro G, Pucci M, Viscomi MT, Lanuti M, Feole M, Angeletti S, Grasselli G, Mandolesi G, Bari M, Centonze D, D'Addario C, Maccarrone M. Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis. Journal of Neuroimmunology. 294: 32-40. PMID 27138096 DOI: 10.1016/J.Jneuroim.2016.03.009 |
0.574 |
|
| 2016 |
Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG, Mandolesi G, Marfia GA, Buttari F, Mori F, Centonze D. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression. Journal of Neuroinflammation. 13: 36. PMID 26863878 DOI: 10.1186/S12974-016-0502-1 |
0.347 |
|
| 2016 |
Motta C, Palermo E, Studer V, Germanotta M, Germani G, Centonze D, Cappa P, Rossi S, Rossi S. Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis. Plos One. 11: e0148997. PMID 26863109 DOI: 10.1371/Journal.Pone.0148997 |
0.306 |
|
| 2016 |
Mori F, Nisticò R, Nicoletti CG, Zagaglia S, Mandolesi G, Piccinin S, Martino G, Finardi A, Rossini PM, Marfia GA, Furlan R, Centonze D. RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26733422 DOI: 10.1177/1352458515621796 |
0.441 |
|
| 2016 |
Comi G, Amato MP, Bertolotto A, Centonze D, De Stefano N, Farina C, Gallo P, Ghezzi A, Grimaldi LM, Mancardi G, Marrosu MG, Montanari E, Patti F, Pozzilli C, Provinciali L, et al. The heritage of glatiramer acetate and its use in multiple sclerosis Multiple Sclerosis and Demyelinating Disorders. 1. DOI: 10.1186/S40893-016-0010-2 |
0.359 |
|
| 2015 |
Ghezzi A, Mutta E, Bianchi F, Bonavita S, Buttari F, Caramma A, Cavarretta R, Centonze D, Coghe GC, Coniglio G, Del Carro U, Ferrò MT, Marrosu MG, Patti F, Rovaris M, et al. Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 26613723 DOI: 10.1007/S10072-015-2415-7 |
0.333 |
|
| 2015 |
Mandolesi G, Gentile A, Musella A, Fresegna D, De Vito F, Bullitta S, Sepman H, Marfia GA, Centonze D. Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nature Reviews. Neurology. PMID 26585978 DOI: 10.1038/Nrneurol.2015.222 |
0.427 |
|
| 2015 |
Gentile A, De Vito F, Fresegna D, Musella A, Buttari F, Bullitta S, Mandolesi G, Centonze D. Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis. Frontiers in Cellular Neuroscience. 9: 243. PMID 26161070 DOI: 10.3389/Fncel.2015.00243 |
0.395 |
|
| 2015 |
Di Mitri D, Sambucci M, Loiarro M, De Bardi M, Volpe E, Cencioni MT, Gasperini C, Centonze D, Sette C, Akbar AN, Borsellino G, Battistini L. The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis. Immunology. 146: 251-63. PMID 26095162 DOI: 10.1111/Imm.12497 |
0.344 |
|
| 2015 |
Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, LeLorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, et al. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group. Multiple Sclerosis and Related Disorders. 4: 202-18. PMID 26008937 DOI: 10.1016/J.Msard.2015.02.005 |
0.346 |
|
| 2015 |
Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barilá D, Battistini L, Volpe E. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death & Disease. 6: e1741. PMID 25950471 DOI: 10.1038/Cddis.2015.100 |
0.316 |
|
| 2015 |
Musella A, Mandolesi G, Mori F, Gentile A, Centonze D. Linking synaptopathy and gray matter damage in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25921048 DOI: 10.1177/1352458515581875 |
0.313 |
|
| 2015 |
Parodi B, Rossi S, Morando S, Cordano C, Bragoni A, Motta C, Usai C, Wipke BT, Scannevin RH, Mancardi GL, Centonze D, Kerlero de Rosbo N, Uccelli A. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathologica. 130: 279-95. PMID 25920452 DOI: 10.1007/S00401-015-1422-3 |
0.451 |
|
| 2015 |
Ruocco G, Rossi S, Motta C, Macchiarulo G, Barbieri F, De Bardi M, Borsellino G, Finardi A, Grasso MG, Ruggieri S, Gasperini C, Furlan R, Centonze D, Battistini L, Volpe E. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis. Clinical Science (London, England : 1979). 129: 291-303. PMID 25700150 DOI: 10.1042/Cs20140608 |
0.364 |
|
| 2015 |
Prosperini L, Annovazzi P, Capobianco M, Capra R, Buttari F, Gasperini C, Galgani S, Solaro C, Centonze D, Bertolotto A, Pozzilli C, Ghezzi A. Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25698174 DOI: 10.1177/1352458515570768 |
0.326 |
|
| 2015 |
Gentile A, Mori F, Bernardini S, Centonze D. Role of amyloid-β CSF levels in cognitive deficit in MS. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 25659291 DOI: 10.1016/J.Cca.2015.01.035 |
0.382 |
|
| 2015 |
Rossi S, Motta C, Studer V, Macchiarulo G, Germani G, Finardi A, Furlan R, Martino G, Centonze D. Subclinical central inflammation is risk for RIS and CIS conversion to MS. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25583841 DOI: 10.1177/1352458514564482 |
0.362 |
|
| 2015 |
Gentile A, Fresegna D, Federici M, Musella A, Rizzo FR, Sepman H, Bullitta S, De Vito F, Haji N, Rossi S, Mercuri NB, Usiello A, Mandolesi G, Centonze D. Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 74: 347-58. PMID 25511803 DOI: 10.1016/J.Nbd.2014.11.022 |
0.388 |
|
| 2015 |
Di Marzo V, Centonze D. Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes. Cns Neuroscience & Therapeutics. 21: 215-21. PMID 25475413 DOI: 10.1111/Cns.12358 |
0.33 |
|
| 2015 |
Mandolesi G, Gentile A, Musella A, Centonze D. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis. Cerebellum (London, England). 14: 19-22. PMID 25326653 DOI: 10.1007/S12311-014-0613-0 |
0.442 |
|
| 2015 |
Rossi S, Motta C, Musella A, Centonze D. The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission. Neuropharmacology. 96: 105-12. PMID 25268960 DOI: 10.1016/J.Neuropharm.2014.09.022 |
0.384 |
|
| 2014 |
Mori F, Ljoka C, Nicoletti CG, Kusayanagi H, Buttari F, Giordani L, Rossi S, Foti C, Centonze D. CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation. 1: e48. PMID 25520956 DOI: 10.1212/Nxi.0000000000000048 |
0.364 |
|
| 2014 |
Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, Weiss S, Battistini L, Martino G, Furlan R, Drulovic J, ... Centonze D, et al. Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Molecular Neurodegeneration. 9: 56. PMID 25495224 DOI: 10.1186/1750-1326-9-56 |
0.337 |
|
| 2014 |
Studer V, Rossi S, Motta C, Buttari F, Centonze D. Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis. Journal of Neuroimmunology. 276: 229-31. PMID 25175066 DOI: 10.1016/J.Jneuroim.2014.08.617 |
0.313 |
|
| 2014 |
Errico F, Nisticò R, Di Giorgio A, Squillace M, Vitucci D, Galbusera A, Piccinin S, Mango D, Fazio L, Middei S, Trizio S, Mercuri NB, Teule MA, Centonze D, Gozzi A, et al. Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. Translational Psychiatry. 4: e417. PMID 25072322 DOI: 10.1038/Tp.2014.59 |
0.324 |
|
| 2014 |
Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V. CD19 as a molecular target in CNS autoimmunity. Acta Neuropathologica. 128: 177-90. PMID 24993505 DOI: 10.1007/S00401-014-1313-Z |
0.302 |
|
| 2014 |
Laricchiuta D, Musella A, Rossi S, Centonze D. Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli. Frontiers in Behavioral Neuroscience. 8: 183. PMID 24904335 DOI: 10.3389/Fnbeh.2014.00183 |
0.303 |
|
| 2014 |
Rossi S, Motta C, Studer V, Rocchi C, Macchiarulo G, Barbieri F, Marfia G, Furlan R, Martino G, Mancino R, Centonze D. Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1841-50. PMID 24876157 DOI: 10.1177/1352458514537365 |
0.307 |
|
| 2014 |
Rossi S, Motta C, Studer V, Boffa L, De Chiara V, Castelli M, Barbieri F, Buttari F, Monteleone F, Germani G, Macchiarulo G, Weiss S, Centonze D. Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids. Cns Neuroscience & Therapeutics. 20: 748-53. PMID 24837039 DOI: 10.1111/Cns.12282 |
0.359 |
|
| 2014 |
Weiss S, Mori F, Rossi S, Centonze D. Disability in multiple sclerosis: when synaptic long-term potentiation fails. Neuroscience and Biobehavioral Reviews. 43: 88-99. PMID 24726576 DOI: 10.1016/J.Neubiorev.2014.03.023 |
0.438 |
|
| 2014 |
Mori F, Nicoletti CG, Rossi S, Motta C, Kusayanagi H, Bergami A, Studer V, Buttari F, Barbieri F, Weiss S, Nisticò R, Martino G, Furlan R, Centonze D. Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis. Neuromolecular Medicine. 16: 490-8. PMID 24671722 DOI: 10.1007/S12017-014-8297-7 |
0.406 |
|
| 2014 |
Rossi S, Studer V, Motta C, Germani G, Macchiarulo G, Buttari F, Mancino R, Castelli M, De Chiara V, Weiss S, Martino G, Furlan R, Centonze D. Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis. Journal of Neuroinflammation. 11: 32. PMID 24548694 DOI: 10.1186/1742-2094-11-32 |
0.315 |
|
| 2014 |
Stefanini M, Fabiano S, Garaci F, Marziali S, Meschini A, Cama V, Fornari M, Rossi S, Centonze D, Gandini R, Simonetti G, Floris R. Phlebographic study does not show differences between patients with MS and control subjects. Ajnr. American Journal of Neuroradiology. 35: 1174-9. PMID 24524919 DOI: 10.3174/Ajnr.A3816 |
0.344 |
|
| 2014 |
Prosperini L, Mancinelli CR, Pozzilli C, Grasso MG, Clemenzi A, Collorone S, Pontecorvo S, Francia A, Villani V, Koudriavtseva T, Buttari F, Centonze D, Di Battista G, Frisullo G, Galgani S, et al. From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter study. European Neurology. 71: 233-41. PMID 24480868 DOI: 10.1159/000356786 |
0.314 |
|
| 2014 |
Musella A, Sepman H, Mandolesi G, Gentile A, Fresegna D, Haji N, Conrad A, Lutz B, Maccarrone M, Centonze D. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis. Neuropharmacology. 79: 567-72. PMID 24440366 DOI: 10.1016/J.Neuropharm.2014.01.007 |
0.418 |
|
| 2014 |
Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, et al. Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 35: 307-16. PMID 24374787 DOI: 10.1007/S10072-013-1616-1 |
0.35 |
|
| 2014 |
Nisticò R, Mori F, Feligioni M, Nicoletti F, Centonze D. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 369: 20130162. PMID 24298163 DOI: 10.1098/Rstb.2013.0162 |
0.434 |
|
| 2014 |
Mori F, Kusayanagi H, Nicoletti CG, Weiss S, Marciani MG, Centonze D. Cortical plasticity predicts recovery from relapse in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 451-7. PMID 24263385 DOI: 10.1177/1352458513512541 |
0.401 |
|
| 2014 |
Mori F, Nisticò R, Mandolesi G, Piccinin S, Mango D, Kusayanagi H, Berretta N, Bergami A, Gentile A, Musella A, Nicoletti CG, Nicoletti F, Buttari F, Mercuri NB, Martino G, ... ... Centonze D, et al. Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis. Neuromolecular Medicine. 16: 38-51. PMID 23892937 DOI: 10.1007/S12017-013-8249-7 |
0.443 |
|
| 2014 |
Rossi S, Motta C, Studer V, Barbieri F, Buttari F, Bergami A, Sancesario G, Bernardini S, De Angelis G, Martino G, Furlan R, Centonze D. Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 304-12. PMID 23886826 DOI: 10.1177/1352458513498128 |
0.432 |
|
| 2014 |
Bacigaluppi M, Russo GL, Peruzzotti-jametti L, Rossi S, Butti E, Ceglia RD, Motta C, Muzio L, Comi G, Centonze D, Invernizzi RW, Hermann DM, Martino G. Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters Journal of Neuroimmunology. 275: 188. DOI: 10.1016/J.Jneuroim.2014.08.506 |
0.317 |
|
| 2013 |
Rossi S, Bozzali M, Bari M, Mori F, Studer V, Motta C, Buttari F, Cercignani M, Gravina P, Mastrangelo N, Castelli M, Mancino R, Nucci C, Sottile F, Bernardini S, ... ... Centonze D, et al. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. Plos One. 8: e82848. PMID 24391723 DOI: 10.1371/Journal.Pone.0082848 |
0.398 |
|
| 2013 |
Basile B, Castelli M, Monteleone F, Nocentini U, Caltagirone C, Centonze D, Cercignani M, Bozzali M. Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1050-1057. PMID 24326671 DOI: 10.1177/1352458513515082 |
0.33 |
|
| 2013 |
Mori F, Rossi S, Piccinin S, Motta C, Mango D, Kusayanagi H, Bergami A, Studer V, Nicoletti CG, Buttari F, Barbieri F, Mercuri NB, Martino G, Furlan R, Nisticò R, ... Centonze D, et al. Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19112-9. PMID 24305808 DOI: 10.1523/Jneurosci.2536-13.2013 |
0.441 |
|
| 2013 |
Musella A, Mandolesi G, Gentile A, Rossi S, Studer V, Motta C, Sepman H, Fresegna D, Haji N, Paolillo A, Matarese G, Centonze D. Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis. Journal of Neuroimmunology. 264: 8-13. PMID 24045165 DOI: 10.1016/J.Jneuroim.2013.08.009 |
0.461 |
|
| 2013 |
Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H, Fresegna D, Bullitta S, De Vito F, Musumeci G, Di Sanza C, Strata P, Centonze D. Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 12105-21. PMID 23864696 DOI: 10.1523/Jneurosci.5369-12.2013 |
0.723 |
|
| 2013 |
De Chiara V, Motta C, Rossi S, Studer V, Barbieri F, Lauro D, Bernardi G, Centonze D. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum. Neuroscience. 250: 232-9. PMID 23856068 DOI: 10.1016/J.Neuroscience.2013.06.069 |
0.319 |
|
| 2013 |
Rossi S, Studer V, Moscatelli A, Motta C, Coghe G, Fenu G, Caillier S, Buttari F, Mori F, Barbieri F, Castelli M, De Chiara V, Monteleone F, Mancino R, Bernardi G, ... ... Centonze D, et al. Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. Plos One. 8: e67357. PMID 23840674 DOI: 10.1371/Journal.Pone.0067357 |
0.413 |
|
| 2013 |
Bari M, Battista N, Valenza M, Mastrangelo N, Malaponti M, Catanzaro G, Centonze D, Finazzi-Agrò A, Cattaneo E, Maccarrone M. In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system. The Febs Journal. 280: 3376-88. PMID 23659592 DOI: 10.1111/Febs.12329 |
0.317 |
|
| 2013 |
Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. Plos Pathogens. 9: e1003220. PMID 23592979 DOI: 10.1371/Journal.Ppat.1003220 |
0.349 |
|
| 2013 |
Chiurchiù V, Cencioni MT, Bisicchia E, De Bardi M, Gasperini C, Borsellino G, Centonze D, Battistini L, Maccarrone M. Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis. Annals of Neurology. 73: 626-36. PMID 23447381 DOI: 10.1002/Ana.23875 |
0.388 |
|
| 2013 |
Gentile A, Rossi S, Studer V, Motta C, De Chiara V, Musella A, Sepman H, Fresegna D, Musumeci G, Grasselli G, Haji N, Weiss S, Hayardeny L, Mandolesi G, Centonze D. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 651-63. PMID 23370991 DOI: 10.1007/S11481-013-9436-X |
0.596 |
|
| 2013 |
Nisticò R, Mango D, Mandolesi G, Piccinin S, Berretta N, Pignatelli M, Feligioni M, Musella A, Gentile A, Mori F, Bernardi G, Nicoletti F, Mercuri NB, Centonze D. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. Plos One. 8: e54666. PMID 23355887 DOI: 10.1371/Journal.Pone.0054666 |
0.416 |
|
| 2013 |
Bozzali M, Spanò B, Parker GJ, Giulietti G, Castelli M, Basile B, Rossi S, Serra L, Magnani G, Nocentini U, Caltagirone C, Centonze D, Cercignani M. Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1161-8. PMID 23325589 DOI: 10.1177/1352458512474088 |
0.338 |
|
| 2013 |
Pieragostino D, Del Boccio P, Di Ioia M, Pieroni L, Greco V, De Luca G, D'Aguanno S, Rossi C, Franciotta D, Centonze D, Sacchetta P, Di Ilio C, Lugaresi A, Urbani A. Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis. Proteomics. 13: 1002-9. PMID 23319365 DOI: 10.1002/Pmic.201200395 |
0.309 |
|
| 2013 |
Ruffini F, Rossi S, Bergamaschi A, Brambilla E, Finardi A, Motta C, Studer V, Barbieri F, De Chiara V, Hayardeny L, Comi G, Centonze D, Martino G. Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1084-94. PMID 23232603 DOI: 10.1177/1352458512469698 |
0.428 |
|
| 2013 |
Mori F, Nicoletti CG, Kusayanagi H, Foti C, Restivo DA, Marciani MG, Centonze D. Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis. Brain Stimulation. 6: 654-9. PMID 23122918 DOI: 10.1016/J.Brs.2012.10.003 |
0.329 |
|
| 2013 |
Restivo DA, Casabona A, Centonze D, Marchese-Ragona R, Maimone D, Pavone A. Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: a pilot study. Brain Stimulation. 6: 418-23. PMID 23040375 DOI: 10.1016/J.Brs.2012.09.001 |
0.342 |
|
| 2013 |
Rieckmann P, Boyko A, Centonze D, Coles A, Elovaara I, Havrdová E, Hommes O, Lelorier J, Morrow SA, Oreja-Guevara C, Rijke N, Schippling S. Future MS care: a consensus statement of the MS in the 21st Century Steering Group. Journal of Neurology. 260: 462-9. PMID 22936203 DOI: 10.1007/S00415-012-6656-6 |
0.35 |
|
| 2013 |
Grasselli G, Rossi S, Musella A, Gentile A, Loizzo S, Muzio L, Di Sanza C, Errico F, Musumeci G, Haji N, Fresegna D, Sepman H, De Chiara V, Furlan R, Martino G, ... ... Centonze D, et al. Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 168: 502-17. PMID 22924679 DOI: 10.1111/J.1476-5381.2012.02178.X |
0.621 |
|
| 2013 |
Rossi S, Motta C, Studer V, De Chiara V, Barbieri F, Monteleone F, Fornasiero A, Coarelli G, Bernardi G, Cutter G, Stüve O, Salvetti M, Centonze D. Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 87-94. PMID 22741530 DOI: 10.1111/J.1468-1331.2012.03794.X |
0.341 |
|
| 2013 |
Rossi S, Motta C, Studer V, Monteleone F, De Chiara V, Buttari F, Barbieri F, Bernardi G, Battistini L, Cutter G, Stüve O, Salvetti M, Centonze D. A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 59-68. PMID 22577119 DOI: 10.1177/1352458512448106 |
0.36 |
|
| 2013 |
Mori F, Kusayanagi H, Monteleone F, Moscatelli A, Nicoletti CG, Bernardi G, Centonze D. Short interval intracortical facilitation correlates with the degree of disability in multiple sclerosis. Brain Stimulation. 6: 67-71. PMID 22425067 DOI: 10.1016/J.Brs.2012.02.001 |
0.395 |
|
| 2012 |
Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D. Interleukin-1β causes anxiety by interacting with the endocannabinoid system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 13896-905. PMID 23035099 DOI: 10.1523/Jneurosci.1515-12.2012 |
0.311 |
|
| 2012 |
Centonze D, Rossi S, Rinaldi F, Gallo P. Severe relapses under fingolimod treatment prescribed after natalizumab. Neurology. 79: 2004-5. PMID 23035063 DOI: 10.1212/Wnl.0B013E3182735C7A |
0.35 |
|
| 2012 |
Garaci FG, Marziali S, Meschini A, Fornari M, Rossi S, Melis M, Fabiano S, Stefanini M, Simonetti G, Centonze D, Floris R. Brain hemodynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity. Radiology. 265: 233-9. PMID 22915599 DOI: 10.1148/Radiol.12112245 |
0.367 |
|
| 2012 |
Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, Musella A, Sepman H, Motta C, Studer V, De Chiara V, Bernardi G, Strata P, Centonze D. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Experimental Neurology. 237: 296-303. PMID 22836148 DOI: 10.1016/J.Expneurol.2012.07.010 |
0.612 |
|
| 2012 |
Rossi S, Studer V, Motta C, De Chiara V, Barbieri F, Bernardi G, Centonze D. Inflammation inhibits GABA transmission in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1633-5. PMID 22419673 DOI: 10.1177/1352458512440207 |
0.415 |
|
| 2012 |
Laricchiuta D, Rossi S, Musella A, De Chiara V, Cutuli D, Centonze D, Petrosini L. Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission. Plos One. 7: e33260. PMID 22413007 DOI: 10.1371/Journal.Pone.0033260 |
0.318 |
|
| 2012 |
Mandolesi G, Grasselli G, Musella A, Gentile A, Musumeci G, Sepman H, Haji N, Fresegna D, Bernardi G, Centonze D. GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 46: 414-24. PMID 22349452 DOI: 10.1016/J.Nbd.2012.02.005 |
0.654 |
|
| 2012 |
Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, Musella A, Bergami A, Muzio L, Bernardi G, Battistini L, Martino G, Centonze D. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Annals of Neurology. 71: 76-83. PMID 22275254 DOI: 10.1002/Ana.22512 |
0.439 |
|
| 2012 |
Floris R, Centonze D, Fabiano S, Stefanini M, Marziali S, Del Giudice C, Reale CA, Castelli M, Garaci F, Melis M, Gandini R, Simonetti G. Prevalence study of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: preliminary data. La Radiologia Medica. 117: 855-64. PMID 22228125 DOI: 10.1007/S11547-011-0767-5 |
0.368 |
|
| 2012 |
Rossi S, Lo Giudice T, De Chiara V, Musella A, Studer V, Motta C, Bernardi G, Martino G, Furlan R, Martorana A, Centonze D. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 165: 861-9. PMID 21740406 DOI: 10.1111/J.1476-5381.2011.01579.X |
0.459 |
|
| 2012 |
Gironi M, Pasquariello N, Franchi S, Pucci M, Martinelli-Boneschi F, Solaro C, Centonze D, Martino G, Sacerdote P, Maccarrone M. Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis". Brain Pathology (Zurich, Switzerland). 22: 79. PMID 21707818 DOI: 10.1111/J.1750-3639.2011.00511.X |
0.317 |
|
| 2012 |
Mori F, Kusayanagi H, Buttari F, Nicoletti CG, Bernardi G, Centonze D. Glatiramer Acetate Reverses Plasticity and Cognitive Deficits Associated with Acute Inflammation in MS (P04.118) Neurology. 78: P04.118-P04.118. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P04.118 |
0.381 |
|
| 2011 |
Castelli M, Federici M, Rossi S, De Chiara V, Napolitano F, Studer V, Motta C, Sacchetti L, Romano R, Musella A, Bernardi G, Siracusano A, Gu HH, Mercuri NB, Usiello A, ... Centonze D, et al. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. The European Journal of Neuroscience. 34: 1369-77. PMID 22034972 DOI: 10.1111/J.1460-9568.2011.07876.X |
0.302 |
|
| 2011 |
Centonze D, Floris R, Stefanini M, Rossi S, Fabiano S, Castelli M, Marziali S, Spinelli A, Motta C, Garaci FG, Bernardi G, Simonetti G. Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Annals of Neurology. 70: 51-8. PMID 21786298 DOI: 10.1002/Ana.22436 |
0.379 |
|
| 2011 |
Mori F, Ribolsi M, Kusayanagi H, Siracusano A, Mantovani V, Marasco E, Bernardi G, Centonze D. Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans. Journal of Neurophysiology. 106: 1637-43. PMID 21753020 DOI: 10.1152/Jn.00318.2011 |
0.324 |
|
| 2011 |
Dalla Libera D, Di Mitri D, Bergami A, Centonze D, Gasperini C, Grasso MG, Galgani S, Martinelli V, Comi G, Avolio C, Martino G, Borsellino G, Sallusto F, Battistini L, Furlan R. T regulatory cells are markers of disease activity in multiple sclerosis patients. Plos One. 6: e21386. PMID 21731726 DOI: 10.1371/Journal.Pone.0021386 |
0.361 |
|
| 2011 |
Rossi S, Mancino R, Bergami A, Mori F, Castelli M, De Chiara V, Studer V, Mataluni G, Sancesario G, Parisi V, Kusayanagi H, Bernardi G, Nucci C, Bernardini S, Martino G, ... ... Centonze D, et al. Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1301-12. PMID 21677024 DOI: 10.1177/1352458511410342 |
0.386 |
|
| 2011 |
Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, Studer V, Bernardi G, Haji N, Sepman H, Fresegna D, Maccarrone M, Mandolesi G, Centonze D. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 43: 669-77. PMID 21672630 DOI: 10.1016/J.Nbd.2011.05.018 |
0.618 |
|
| 2011 |
Rossi S, Furlan R, De Chiara V, Muzio L, Musella A, Motta C, Studer V, Cavasinni F, Bernardi G, Martino G, Cravatt BF, Lutz B, Maccarrone M, Centonze D. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 25: 1242-8. PMID 21473912 DOI: 10.1016/J.Bbi.2011.03.017 |
0.441 |
|
| 2011 |
Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz MA, Cicconi L, Bernardi G, Centonze D, Lo-Coco F. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology. 76: 1059-65. PMID 21346221 DOI: 10.1212/Wnl.0B013E318211C3C8 |
0.306 |
|
| 2011 |
Maccarrone M, Bernardi G, Agrò AF, Centonze D. Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. British Journal of Pharmacology. 163: 1379-90. PMID 21323908 DOI: 10.1111/J.1476-5381.2011.01277.X |
0.309 |
|
| 2011 |
Bagnato F, Centonze D, Galgani S, Grasso MG, Haggiag S, Strano S. Painful and involuntary multiple sclerosis. Expert Opinion On Pharmacotherapy. 12: 763-77. PMID 21323633 DOI: 10.1517/14656566.2011.540239 |
0.318 |
|
| 2011 |
Mori F, Ljoka C, Magni E, Codecà C, Kusayanagi H, Monteleone F, Sancesario A, Bernardi G, Koch G, Foti C, Centonze D. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology. 258: 1281-7. PMID 21286740 DOI: 10.1007/S00415-011-5924-1 |
0.34 |
|
| 2011 |
Ghezzi A, Grimaldi LM, Marrosu MG, Pozzilli C, Comi G, Bertolotto A, Trojano M, Gallo P, Capra R, Centonze D, Millefiorini E, Sotgiu S, Brescia Morra V, Amato MP, Lugaresi A, et al. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 32: 351-8. PMID 21234775 DOI: 10.1007/S10072-010-0469-0 |
0.372 |
|
| 2011 |
Cutuli D, Rossi S, Burello L, Laricchiuta D, De Chiara V, Foti F, De Bartolo P, Musella A, Gelfo F, Centonze D, Petrosini L. Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin. Neurobiology of Disease. 42: 9-20. PMID 21182946 DOI: 10.1016/J.Nbd.2010.12.007 |
0.37 |
|
| 2011 |
Rossi S, Buttari F, Studer V, Motta C, Gravina P, Castelli M, Mantovani V, De Chiara V, Musella A, Fiore S, Masini S, Bernardi G, Maccarrone M, Bernardini S, Centonze D. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 281-8. PMID 21148019 DOI: 10.1177/1352458510388680 |
0.391 |
|
| 2011 |
Mori F, Rossi S, Sancesario G, Codecà C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D. Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 559-68. PMID 20944553 DOI: 10.1038/Npp.2010.187 |
0.352 |
|
| 2011 |
Rossi S, Muzio L, De Chiara V, Grasselli G, Musella A, Musumeci G, Mandolesi G, De Ceglia R, Maida S, Biffi E, Pedrocchi A, Menegon A, Bernardi G, Furlan R, Martino G, ... Centonze D, et al. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 25: 947-56. PMID 20940040 DOI: 10.1016/J.Bbi.2010.10.004 |
0.635 |
|
| 2010 |
Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, et al. Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Annals of Neurology. 68: 409-11. PMID 20818795 DOI: 10.1002/Ana.22083 |
0.326 |
|
| 2010 |
Codecà C, Mori F, Kusayanagi H, Monteleone F, Boffa L, Paolillo A, Bernardi G, Koch G, Centonze D. Differential patterns of interhemispheric functional disconnection in mild and advanced multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1308-16. PMID 20702503 DOI: 10.1177/1352458510376957 |
0.359 |
|
| 2010 |
Rossi S, De Chiara V, Furlan R, Musella A, Cavasinni F, Muzio L, Bernardi G, Martino G, Centonze D. Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 24: 1379-85. PMID 20647042 DOI: 10.1016/J.Bbi.2010.07.241 |
0.352 |
|
| 2010 |
Mandolesi G, Grasselli G, Musumeci G, Centonze D. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 31: S255-9. PMID 20635112 DOI: 10.1007/S10072-010-0369-3 |
0.63 |
|
| 2010 |
Rossi S, De Chiara V, Musella A, Sacchetti L, Cantarella C, Castelli M, Cavasinni F, Motta C, Studer V, Bernardi G, Cravatt BF, Maccarrone M, Usiello A, Centonze D. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Molecular Pharmacology. 78: 260-8. PMID 20424126 DOI: 10.1124/Mol.110.064196 |
0.348 |
|
| 2010 |
Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A, Bernardi G, Bagni C, Centonze D. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1500-9. PMID 20393458 DOI: 10.1038/Npp.2010.19 |
0.592 |
|
| 2010 |
Rossi S, Bernardi G, Centonze D. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis. Experimental Neurology. 224: 92-102. PMID 20353778 DOI: 10.1016/J.Expneurol.2010.03.030 |
0.386 |
|
| 2010 |
Musella A, De Chiara V, Rossi S, Cavasinni F, Castelli M, Cantarella C, Mataluni G, Bernardi G, Centonze D. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience. 167: 864-71. PMID 20219639 DOI: 10.1016/J.Neuroscience.2010.02.058 |
0.349 |
|
| 2010 |
Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Siracusano A, Bernardi G, Usiello A, Centonze D. Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors. Molecular Nutrition & Food Research. 54: 525-31. PMID 20087854 DOI: 10.1002/Mnfr.200900237 |
0.321 |
|
| 2010 |
Spanò B, Cercignani M, Basile B, Romano S, Mannu R, Centonze D, Caltagirone C, Bramanti P, Nocentini U, Bozzali M. Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 178-88. PMID 20007429 DOI: 10.1177/1352458509356010 |
0.344 |
|
| 2010 |
Centonze D, Muzio L, Rossi S, Furlan R, Bernardi G, Martino G. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death and Differentiation. 17: 1083-91. PMID 19927157 DOI: 10.1038/Cdd.2009.179 |
0.459 |
|
| 2010 |
Mori F, Codecà C, Kusayanagi H, Monteleone F, Boffa L, Rimano A, Bernardi G, Koch G, Centonze D. Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 295-300. PMID 19863647 DOI: 10.1111/J.1468-1331.2009.02806.X |
0.36 |
|
| 2010 |
De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, Usiello A, Centonze D. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 374-87. PMID 19776732 DOI: 10.1038/Npp.2009.141 |
0.371 |
|
| 2010 |
Rossi S, De Chiara V, Musella A, Cozzolino M, Bernardi G, Maccarrone M, Mercuri NB, Carrì MT, Centonze D. Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 83-90. PMID 19452308 DOI: 10.3109/17482960902977954 |
0.391 |
|
| 2009 |
Koch G, Mori F, Codecà C, Kusayanagi H, Monteleone F, Buttari F, Fiore S, Bernardi G, Centonze D. Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans. Brain Stimulation. 2: 229-33. PMID 20633421 DOI: 10.1016/J.Brs.2009.03.001 |
0.346 |
|
| 2009 |
Centonze D, Mori F, Koch G, Buttari F, Codecà C, Rossi S, Cencioni MT, Bari M, Fiore S, Bernardi G, Battistini L, Maccarrone M. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 30: 531-4. PMID 19768368 DOI: 10.1007/S10072-009-0136-5 |
0.383 |
|
| 2009 |
D'Argenzio L, Koch G, Bombardieri R, Mori F, Moavero R, Centonze D, Curatolo P. Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex. Epilepsy Research. 87: 102-5. PMID 19713078 DOI: 10.1016/J.Eplepsyres.2009.07.009 |
0.303 |
|
| 2009 |
Mori F, Koch G, Foti C, Bernardi G, Centonze D. The use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of spasticity. Progress in Brain Research. 175: 429-39. PMID 19660671 DOI: 10.1016/S0079-6123(09)17528-3 |
0.333 |
|
| 2009 |
Rossi S, Furlan R, De Chiara V, Musella A, Lo Giudice T, Mataluni G, Cavasinni F, Cantarella C, Bernardi G, Muzio L, Martorana A, Martino G, Centonze D. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiology of Disease. 36: 51-9. PMID 19591937 DOI: 10.1016/J.Nbd.2009.06.013 |
0.35 |
|
| 2009 |
Rossi S, Mataluni G, Codecà C, Fiore S, Buttari F, Musella A, Castelli M, Bernardi G, Centonze D. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 360-6. PMID 19364364 DOI: 10.1111/J.1468-1331.2008.02496.X |
0.309 |
|
| 2009 |
Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D'Amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni MT, Diamantini A, Butti E, Comi G, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 3442-52. PMID 19295150 DOI: 10.1523/Jneurosci.5804-08.2009 |
0.396 |
|
| 2009 |
Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Bernardi G, Usiello A, Centonze D. Adaptations of striatal endocannabinoid system during stress. Molecular Neurobiology. 39: 178-84. PMID 19267225 DOI: 10.1007/S12035-009-8061-4 |
0.308 |
|
| 2009 |
Maccarrone M, De Chiara V, Gasperi V, Viscomi MT, Rossi S, Oddi S, Molinari M, Musella A, Finazzi-Agrò A, Centonze D. Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. Journal of Neurochemistry. 109: 371-81. PMID 19187444 DOI: 10.1111/J.1471-4159.2009.05948.X |
0.341 |
|
| 2009 |
Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Siracusano A, Bernardi G, Usiello A, Centonze D. Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects. Neuropharmacology. 56: 590-7. PMID 19027757 DOI: 10.1016/J.Neuropharm.2008.10.013 |
0.337 |
|
| 2009 |
Tashev R, Moura PJ, Venkitaramani DV, Prosperetti C, Centonze D, Paul S, Lombroso PJ. A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum. Biological Psychiatry. 65: 637-45. PMID 19026408 DOI: 10.1016/J.Biopsych.2008.10.008 |
0.304 |
|
| 2009 |
Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, Centonze D. TRPV1 channels facilitate glutamate transmission in the striatum. Molecular and Cellular Neurosciences. 40: 89-97. PMID 18930149 DOI: 10.1016/J.Mcn.2008.09.001 |
0.342 |
|
| 2009 |
Gironi M, Pasquariello N, Franchi S, Sacerdote P, Martino G, Martinelli-Boneschi F, Martinelli V, Comi G, Nemni R, Solaro C, Centonze D, Maccarone M. FP48-TH-05 Study of low dose naltrexone modulation of the endocannabinoid system in patients with multiple sclerosis Journal of the Neurological Sciences. 285. DOI: 10.1016/S0022-510X(09)70527-1 |
0.307 |
|
| 2008 |
Centonze D, Battistini L, Maccarrone M. The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Current Pharmaceutical Design. 14: 2370-42. PMID 18781987 DOI: 10.2174/138161208785740018 |
0.313 |
|
| 2008 |
Centonze D, Furlan R, Gasperini C, Salvetti M, Battistini L. Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1137-8. PMID 18701574 DOI: 10.1177/1352458508092810 |
0.341 |
|
| 2008 |
Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7284-92. PMID 18632932 DOI: 10.1523/Jneurosci.5346-07.2008 |
0.339 |
|
| 2008 |
Koch G, Rossi S, Prosperetti C, Codecà C, Monteleone F, Petrosini L, Bernardi G, Centonze D. Improvement of hand dexterity following motor cortex rTMS in multiple sclerosis patients with cerebellar impairment. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 995-8. PMID 18573820 DOI: 10.1177/1352458508088710 |
0.34 |
|
| 2008 |
Centonze D, Rossi S, De Bartolo P, De Chiara V, Foti F, Musella A, Mataluni G, Rossi S, Bernardi G, Koch G, Petrosini L. Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage. The European Journal of Neuroscience. 27: 2188-96. PMID 18412636 DOI: 10.1111/J.1460-9568.2008.06182.X |
0.381 |
|
| 2008 |
Napolitano M, Zei D, Centonze D, Palermo R, Bernardi G, Vacca A, Calabresi P, Gulino A. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease. Neuroscience Letters. 434: 241-6. PMID 18329171 DOI: 10.1016/J.Neulet.2007.09.056 |
0.301 |
|
| 2008 |
Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agrò A, Cravatt BF, Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience. 11: 152-9. PMID 18204441 DOI: 10.1038/Nn2042 |
0.301 |
|
| 2008 |
Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/J.Mcn.2007.10.007 |
0.304 |
|
| 2008 |
Centonze D, Rossi S, Mercaldo V, Napoli I, Ciotti MT, De Chiara V, Musella A, Prosperetti C, Calabresi P, Bernardi G, Bagni C. Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biological Psychiatry. 63: 963-73. PMID 18028882 DOI: 10.1016/J.Biopsych.2007.09.008 |
0.599 |
|
| 2008 |
Errico F, Nisticò R, Palma G, Federici M, Affuso A, Brilli E, Topo E, Centonze D, Bernardi G, Bozzi Y, D'Aniello A, Di Lauro R, Mercuri NB, Usiello A. Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. Molecular and Cellular Neurosciences. 37: 236-46. PMID 17981050 DOI: 10.1016/J.Mcn.2007.09.012 |
0.316 |
|
| 2008 |
Bari M, Oddi S, De Simone C, Spagnolo P, Gasperi V, Battista N, Centonze D, Maccarrone M. Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology. 54: 45-50. PMID 17714745 DOI: 10.1016/J.Neuropharm.2007.06.030 |
0.301 |
|
| 2008 |
Mori F, Codecà C, Kusayanagi H, Monteleone F, Koch G, Centonze D. Effect of Sativex® chronic therapy on TBS modulation of motor cortex excitability in MS patients Brain Stimulation. 1: 262. DOI: 10.1016/J.Brs.2008.06.051 |
0.329 |
|
| 2008 |
Codecà C, Mori F, Kusayanagi H, Monteleone F, Centonze D, Koch G. iTBS of primary motor cortex improves spasticity in MS patients Brain Stimulation. 1: 267. DOI: 10.1016/J.Brs.2008.06.014 |
0.326 |
|
| 2007 |
Centonze D, Bernardi G, Koch G. Mechanisms of disease: basic-research-driven investigations in humans--the case of hyperkinetic disorders. Nature Clinical Practice. Neurology. 3: 572-80. PMID 17914345 DOI: 10.1038/Ncpneuro0617 |
0.345 |
|
| 2007 |
Tozzi A, Tscherter A, Belcastro V, Tantucci M, Costa C, Picconi B, Centonze D, Calabresi P, Borsini F. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Neuropharmacology. 53: 783-9. PMID 17889039 DOI: 10.1016/J.Neuropharm.2007.08.006 |
0.356 |
|
| 2007 |
Centonze D, Rossi S, Napoli I, Mercaldo V, Lacoux C, Ferrari F, Ciotti MT, De Chiara V, Prosperetti C, Maccarrone M, Fezza F, Calabresi P, Bernardi G, Bagni C. The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8885-92. PMID 17699670 DOI: 10.1523/Jneurosci.0548-07.2007 |
0.586 |
|
| 2007 |
Centonze D, Rossi S, Finazzi-Agrò A, Bernardi G, Maccarrone M. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. International Review of Neurobiology. 82: 171-86. PMID 17678961 DOI: 10.1016/S0074-7742(07)82009-5 |
0.397 |
|
| 2007 |
Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, De Chiara V, Battistini L, Bernardi G, Bernardini S, Martino G, Maccarrone M. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain : a Journal of Neurology. 130: 2543-53. PMID 17626034 DOI: 10.1093/Brain/Awm160 |
0.448 |
|
| 2007 |
Centonze D, Rossi S, Tortiglione A, Picconi B, Prosperetti C, De Chiara V, Bernardi G, Calabresi P. Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery. Neurobiology of Disease. 27: 44-53. PMID 17490888 DOI: 10.1016/J.Nbd.2007.03.012 |
0.371 |
|
| 2007 |
Centonze D, Petta F, Versace V, Rossi S, Torelli F, Prosperetti C, Rossi S, Marfia GA, Bernardi G, Koch G, Miano R, Boffa L, Finazzi-Agrò E. Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 269-71. PMID 17439897 DOI: 10.1177/1352458506070729 |
0.331 |
|
| 2007 |
Centonze D, Rossi S, Prosperetti C, Gasperi V, De Chiara V, Bari M, Tscherter A, Febbraro F, Bernardi G, Maccarrone M. Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons. Molecular and Cellular Neurosciences. 35: 302-10. PMID 17434747 DOI: 10.1016/J.Mcn.2007.03.005 |
0.392 |
|
| 2007 |
Tortiglione A, Picconi B, Barone I, Centonze D, Rossi S, Costa C, Di Filippo M, Tozzi A, Tantucci M, Bernardi G, Annunziato L, Calabresi P. Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. Stroke; a Journal of Cerebral Circulation. 38: 1614-20. PMID 17395860 DOI: 10.1161/Strokeaha.106.478644 |
0.306 |
|
| 2007 |
Centonze D, Koch G, Versace V, Mori F, Rossi S, Brusa L, Grossi K, Torelli F, Prosperetti C, Cervellino A, Marfia GA, Stanzione P, Marciani MG, Boffa L, Bernardi G. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis. Neurology. 68: 1045-50. PMID 17389310 DOI: 10.1212/01.Wnl.0000257818.16952.62 |
0.304 |
|
| 2007 |
Centonze D, Finazzi-Agrò A, Bernardi G, Maccarrone M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends in Pharmacological Sciences. 28: 180-7. PMID 17350694 DOI: 10.1016/J.Tips.2007.02.004 |
0.303 |
|
| 2007 |
Maccarrone M, Battista N, Centonze D. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Progress in Neurobiology. 81: 349-79. PMID 17276576 DOI: 10.1016/J.Pneurobio.2006.11.006 |
0.33 |
|
| 2006 |
Rossi S, Prosperetti C, Picconi B, De Chiara V, Mataluni G, Bernardi G, Calabresi P, Centonze D. Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. Neuroscience Letters. 410: 6-10. PMID 17070651 DOI: 10.1016/J.Neulet.2006.09.056 |
0.364 |
|
| 2006 |
Centonze D, Rossi S, Gubellini P, De Chiara V, Tscherter A, Prosperetti C, Picconi B, Bernardi G, Calabresi P, Baunez C. Deficits of glutamate transmission in the striatum of experimental hemiballism. Neuroscience. 143: 213-21. PMID 16938405 DOI: 10.1016/J.Neuroscience.2006.07.024 |
0.337 |
|
| 2006 |
Centonze D, Prosperetti C, Barone I, Rossi S, Picconi B, Tscherter A, De Chiara V, Bernardi G, Calabresi P. NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. Experimental Neurology. 202: 470-9. PMID 16919272 DOI: 10.1016/J.Expneurol.2006.07.009 |
0.346 |
|
| 2006 |
Brusa L, Versace V, Koch G, Iani C, Stanzione P, Bernardi G, Centonze D. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 117: 1917-21. PMID 16887383 DOI: 10.1016/J.Clinph.2006.03.033 |
0.3 |
|
| 2006 |
Picconi B, Tortiglione A, Barone I, Centonze D, Gardoni F, Gubellini P, Bonsi P, Pisani A, Bernardi G, Di Luca M, Calabresi P. NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke; a Journal of Cerebral Circulation. 37: 1895-901. PMID 16741178 DOI: 10.1161/01.Str.0000226981.57777.B0 |
0.353 |
|
| 2006 |
Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, et al. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience. 140: 897-911. PMID 16600521 DOI: 10.1016/J.Neuroscience.2006.02.067 |
0.353 |
|
| 2006 |
Centonze D, Costa C, Rossi S, Prosperetti C, Pisani A, Usiello A, Bernardi G, Mercuri NB, Calabresi P. Chronic cocaine prevents depotentiation at corticostriatal synapses. Biological Psychiatry. 60: 436-43. PMID 16476411 DOI: 10.1016/J.Biopsych.2005.11.018 |
0.303 |
|
| 2005 |
Koch G, Brusa L, Caltagirone C, Peppe A, Oliveri M, Stanzione P, Centonze D. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology. 65: 623-5. PMID 16116131 DOI: 10.1212/01.Wnl.0000172861.36430.95 |
0.308 |
|
| 2005 |
Bonsi P, Cuomo D, De Persis C, Centonze D, Bernardi G, Calabresi P, Pisani A. Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology. 49: 104-13. PMID 16005029 DOI: 10.1016/J.Neuropharm.2005.05.012 |
0.355 |
|
| 2005 |
Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, Calabresi P. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biological Psychiatry. 57: 1583-9. PMID 15953496 DOI: 10.1016/J.Biopsych.2005.03.008 |
0.365 |
|
| 2005 |
Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology. 26: 779-83. PMID 15927256 DOI: 10.1016/J.Neuro.2005.02.002 |
0.361 |
|
| 2005 |
Centonze D, Gubellini P, Rossi S, Picconi B, Pisani A, Bernardi G, Calabresi P, Baunez C. Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. Neuroscience. 133: 831-40. PMID 15893432 DOI: 10.1016/J.Neuroscience.2005.03.006 |
0.329 |
|
| 2005 |
Pisani A, Centonze D, Bernardi G, Calabresi P. Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 395-402. PMID 15719415 DOI: 10.1002/Mds.20394 |
0.365 |
|
| 2005 |
Centonze D, Rossi S, Boffa L, Versace V, Palmieri MG, Caramia MD, Bernardi G. CSF from MS patients can induce acute conduction block in the isolated optic nerve. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 12: 45-8. PMID 15613146 DOI: 10.1111/J.1468-1331.2004.00946.X |
0.364 |
|
| 2004 |
Gubellini P, Pisani A, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Progress in Neurobiology. 74: 271-300. PMID 15582223 DOI: 10.1016/J.Pneurobio.2004.09.005 |
0.394 |
|
| 2004 |
Centonze D, Gubellini P, Usiello A, Rossi S, Tscherter A, Bracci E, Erbs E, Tognazzi N, Bernardi G, Pisani A, Calabresi P, Borrelli E. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience. 129: 157-66. PMID 15489038 DOI: 10.1016/J.Neuroscience.2004.07.043 |
0.345 |
|
| 2004 |
Centonze D, Usiello A, Costa C, Picconi B, Erbs E, Bernardi G, Borrelli E, Calabresi P. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 8214-22. PMID 15385604 DOI: 10.1523/Jneurosci.1274-04.2004 |
0.366 |
|
| 2004 |
Bracci E, Centonze D, Bernardi G, Calabresi P. Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings. Journal of Neurophysiology. 92: 2725-37. PMID 15240765 DOI: 10.1152/Jn.00585.2004 |
0.348 |
|
| 2004 |
Picconi B, Gardoni F, Centonze D, Mauceri D, Cenci MA, Bernardi G, Calabresi P, Di Luca M. Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5283-91. PMID 15190099 DOI: 10.1523/Jneurosci.1224-04.2004 |
0.358 |
|
| 2004 |
Picconi B, Centonze D, Rossi S, Bernardi G, Calabresi P. Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. Brain : a Journal of Neurology. 127: 1661-9. PMID 15155524 DOI: 10.1093/Brain/Awh190 |
0.35 |
|
| 2004 |
Gubellini P, Centonze D, Tropepi D, Bernardi G, Calabresi P. Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway. Neuropharmacology. 46: 761-9. PMID 15033336 DOI: 10.1016/J.Neuropharm.2003.11.021 |
0.347 |
|
| 2004 |
Napolitano M, Centonze D, Gubellini P, Rossi S, Spiezia S, Bernardi G, Gulino A, Calabresi P. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease. Neurobiology of Disease. 15: 407-14. PMID 15006711 DOI: 10.1016/J.Nbd.2003.11.021 |
0.303 |
|
| 2004 |
Caramia MD, Palmieri MG, Desiato MT, Boffa L, Galizia P, Rossini PM, Centonze D, Bernardi G. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 115: 956-65. PMID 15003779 DOI: 10.1016/J.Clinph.2003.11.024 |
0.414 |
|
| 2004 |
Saulle E, Gubellini P, Picconi B, Centonze D, Tropepi D, Pisani A, Morari M, Marti M, Rossi L, Papa M, Bernardi G, Calabresi P. Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. Molecular and Cellular Neurosciences. 25: 9-20. PMID 14962736 DOI: 10.1016/J.Mcn.2003.09.013 |
0.315 |
|
| 2003 |
Centonze D, Gubellini P, Pisani A, Bernardi G, Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Reviews in the Neurosciences. 14: 207-16. PMID 14513864 DOI: 10.1515/Revneuro.2003.14.3.207 |
0.365 |
|
| 2003 |
Calabresi P, Centonze D, Pisani A, Cupini L, Bernardi G. Synaptic plasticity in the ischaemic brain. The Lancet. Neurology. 2: 622-9. PMID 14505584 DOI: 10.1016/S1474-4422(03)00532-5 |
0.342 |
|
| 2003 |
Calabresi P, Marti M, Picconi B, Saulle E, Costa C, Centonze D, Pisani F, Bernardi G. Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Experimental Neurology. 182: 461-9. PMID 12895457 DOI: 10.1016/S0014-4886(03)00117-1 |
0.38 |
|
| 2003 |
Centonze D, Grande C, Usiello A, Gubellini P, Erbs E, Martin AB, Pisani A, Tognazzi N, Bernardi G, Moratalla R, Borrelli E, Calabresi P. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6245-54. PMID 12867509 DOI: 10.1523/Jneurosci.23-15-06245.2003 |
0.314 |
|
| 2003 |
Pisani A, Bonsi P, Centonze D, Gubellini P, Bernardi G, Calabresi P. Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors. Neuropharmacology. 45: 45-56. PMID 12814658 DOI: 10.1016/S0028-3908(03)00137-0 |
0.357 |
|
| 2003 |
Maccarrone M, Gubellini P, Bari M, Picconi B, Battista N, Centonze D, Bernardi G, Finazzi-Agrò A, Calabresi P. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. Journal of Neurochemistry. 85: 1018-25. PMID 12716433 DOI: 10.1046/J.1471-4159.2003.01759.X |
0.37 |
|
| 2003 |
Picconi B, Centonze D, HÃ¥kansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neuroscience. 6: 501-6. PMID 12665799 DOI: 10.1038/Nn1040 |
0.344 |
|
| 2003 |
Calabresi P, Centonze D, Cupini LM, Costa C, Pisani F, Bernardi G. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. Neurobiology of Disease. 12: 82-8. PMID 12609492 DOI: 10.1016/S0969-9961(02)00016-5 |
0.36 |
|
| 2003 |
Gubellini P, Saulle E, Centonze D, Costa C, Tropepi D, Bernardi G, Conquet F, Calabresi P. Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. Neuropharmacology. 44: 8-16. PMID 12559117 DOI: 10.1016/S0028-3908(02)00214-9 |
0.366 |
|
| 2003 |
Tofighy A, Abbott A, Centonze D, Cooper AJ, Noor E, Pearce SM, Puntis M, Stanford IM, Wigmore MA, Lacey MG. Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology. Neuroscience. 116: 157-66. PMID 12535949 DOI: 10.1016/S0306-4522(02)00546-8 |
0.318 |
|
| 2002 |
Saulle E, Centonze D, MartÃn AB, Moratalla R, Bernardi G, Calabresi P. Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors. Stroke; a Journal of Cerebral Circulation. 33: 2978-84. PMID 12468800 DOI: 10.1161/01.Str.0000038093.42512.0F |
0.36 |
|
| 2002 |
Centonze D, Usiello A, Gubellini P, Pisani A, Borrelli E, Bernardi G, Calabresi P. Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 723-6. PMID 12431847 DOI: 10.1016/S0893-133X(02)00367-6 |
0.313 |
|
| 2002 |
Picconi B, Pisani A, Centonze D, Battaglia G, Storto M, Nicoletti F, Bernardi G, Calabresi P. Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. Brain : a Journal of Neurology. 125: 2635-45. PMID 12429591 DOI: 10.1093/Brain/Awf269 |
0.363 |
|
| 2002 |
Napolitano M, Centonze D, Calce A, Picconi B, Spiezia S, Gulino A, Bernardi G, Calabresi P. Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum. Neurobiology of Disease. 10: 387-95. PMID 12270699 DOI: 10.1006/Nbdi.2002.0525 |
0.321 |
|
| 2002 |
Centonze D, Napolitano M, Saulle E, Gubellini P, Picconi B, Martorana A, Pisani A, Gulino A, Bernardi G, Calabresi P. Tissue plasminogen activator is required for corticostriatal long-term potentiation. The European Journal of Neuroscience. 16: 713-21. PMID 12270047 DOI: 10.1046/J.1460-9568.2002.02106.X |
0.379 |
|
| 2002 |
Centonze D, Bracci E, Pisani A, Gubellini P, Bernardi G, Calabresi P. Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. The European Journal of Neuroscience. 15: 2049-52. PMID 12099911 DOI: 10.1046/J.1460-9568.2002.02052.X |
0.332 |
|
| 2002 |
Bracci E, Centonze D, Bernardi G, Calabresi P. Dopamine excites fast-spiking interneurons in the striatum. Journal of Neurophysiology. 87: 2190-4. PMID 11929936 DOI: 10.1152/Jn.00754.2001 |
0.333 |
|
| 2002 |
Centonze D, Saulle E, Pisani A, Bonsi P, Tropepi D, Bernardi G, Calabresi P. Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation. Neuroreport. 13: 115-8. PMID 11924871 DOI: 10.1097/00001756-200201210-00027 |
0.344 |
|
| 2002 |
Calabresi P, Saulle E, Centonze D, Pisani A, Marfia GA, Bernardi G. Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. Brain : a Journal of Neurology. 125: 844-60. PMID 11912117 DOI: 10.1093/Brain/Awf073 |
0.352 |
|
| 2002 |
Centonze D, Picconi B, Baunez C, Borrelli E, Pisani A, Bernardi G, Calabresi P. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 164-75. PMID 11790512 DOI: 10.1016/S0893-133X(01)00299-8 |
0.348 |
|
| 2002 |
Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agrò A, Maccarrone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. The Journal of Neuroscience. 22: 6900-6907. DOI: 10.1523/Jneurosci.22-16-06900.2002 |
0.345 |
|
| 2002 |
Pisani A, Bonsi P, Catania MV, Giuffrida R, Morari M, Marti M, Centonze D, Bernardi G, Kingston AE, Calabresi P. Metabotropic Glutamate 2 Receptors Modulate Synaptic Inputs and Calcium Signals in Striatal Cholinergic Interneurons The Journal of Neuroscience. 22: 6176-6185. DOI: 10.1523/Jneurosci.22-14-06176.2002 |
0.365 |
|
| 2001 |
Centonze D, Gubellini P, Bernardi G, Calabresi P. Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese. Experimental Neurology. 172: 469-76. PMID 11716571 DOI: 10.1006/Exnr.2001.7812 |
0.397 |
|
| 2001 |
Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience. 106: 579-87. PMID 11591458 DOI: 10.1016/S0306-4522(01)00297-4 |
0.347 |
|
| 2001 |
Centonze D, Saulle E, Pisani A, Bernardi G, Calabresi P. Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. Brain : a Journal of Neurology. 124: 1855-65. PMID 11522587 DOI: 10.1093/Brain/124.9.1855 |
0.374 |
|
| 2001 |
Centonze D, Gubellini P, Picconi B, Saulle E, Tolu M, Bonsi P, Giacomini P, Calabresi P. An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 22: 61-2. PMID 11487202 DOI: 10.1007/S100720170047 |
0.391 |
|
| 2001 |
Calabresi P, Ammassari-Teule M, Gubellini P, Sancesario G, Morello M, Centonze D, Marfia GA, Saulle E, Passino E, Picconi B, Bernardi G. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiology of Disease. 8: 419-32. PMID 11442351 DOI: 10.1006/Nbdi.2000.0379 |
0.377 |
|
| 2001 |
Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind RA, Borrelli E, Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5110-20. PMID 11438586 DOI: 10.1523/Jneurosci.21-14-05110.2001 |
0.386 |
|
| 2001 |
Battaglia G, Bruno V, Pisani A, Centonze D, Catania MV, Calabresi P, Nicoletti F. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Molecular and Cellular Neurosciences. 17: 1071-83. PMID 11414795 DOI: 10.1006/Mcne.2001.0992 |
0.336 |
|
| 2001 |
Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P. Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology. 40: 839-46. PMID 11378154 DOI: 10.1016/S0028-3908(01)00021-1 |
0.401 |
|
| 2001 |
Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. The European Journal of Neuroscience. 13: 1071-7. PMID 11285003 DOI: 10.1046/J.0953-816X.2001.01485.X |
0.385 |
|
| 2001 |
Pisani A, Bonsi P, Centonze D, Bernardi G, Calabresi P. Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons. Neuropharmacology. 40: 460-3. PMID 11166340 DOI: 10.1016/S0028-3908(00)00184-2 |
0.344 |
|
| 2001 |
Centonze D, Pisani A, Bonsi P, Giacomini P, Bernardi G, Calabresi P. Stimulation of Nitric Oxide–cGMP Pathway Excites Striatal Cholinergic Interneurons via Protein Kinase G Activation The Journal of Neuroscience. 21: 1393-1400. DOI: 10.1523/Jneurosci.21-04-01393.2001 |
0.324 |
|
| 2000 |
Calabresi P, Centonze D, Bernardi G. Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology. 55: 1249-55. PMID 11092223 DOI: 10.1212/Wnl.55.9.1249 |
0.36 |
|
| 2000 |
Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8443-51. PMID 11069952 DOI: 10.1523/Jneurosci.20-22-08443.2000 |
0.347 |
|
| 2000 |
Calabresi P, Centonze D, Bernardi G. Electrophysiology of dopamine in normal and denervated striatal neurons. Trends in Neurosciences. 23: S57-63. PMID 11052221 DOI: 10.1016/S1471-1931(00)00017-3 |
0.32 |
|
| 2000 |
Pisani A, Bernardi G, Bonsi P, Centonze D, Giacomini P, Calabresi P. Cell-type specificity of mGluR activation in striatal neuronal subtypes. Amino Acids. 19: 119-29. PMID 11026480 DOI: 10.1007/S007260070040 |
0.348 |
|
| 2000 |
Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, Gulino A. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. The European Journal of Neuroscience. 12: 1002-12. PMID 10762331 DOI: 10.1046/J.1460-9568.2000.00991.X |
0.327 |
|
| 2000 |
Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario G, Bernardi G. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Progress in Neurobiology. 61: 231-65. PMID 10727775 DOI: 10.1016/S0301-0082(99)00030-1 |
0.39 |
|
| 2000 |
Calabresi P, Stefani A, Marfia GA, Hainsworth AH, Centonze D, Saulle E, Spadoni F, Leach MJ, Giacomini P, Bernardi G. Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. Experimental Neurology. 162: 171-9. PMID 10716897 DOI: 10.1006/Exnr.2000.7285 |
0.322 |
|
| 2000 |
Calabresi P, Picconi B, Saulle E, Centonze D, Hainsworth AH, Bernardi G. Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke; a Journal of Cerebral Circulation. 31: 766-72; discussion 7. PMID 10700517 DOI: 10.1161/01.Str.31.3.766 |
0.359 |
|
| 2000 |
Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends in Neurosciences. 23: 120-6. PMID 10675916 DOI: 10.1016/S0166-2236(99)01501-5 |
0.359 |
|
| 2000 |
Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. The Journal of Neuroscience. 20. DOI: 10.1523/Jneurosci.20-07-J0003.2000 |
0.384 |
|
| 1999 |
Centonze D, Calabresi P, Giacomini P, Bernardi G. Neurophysiology of Parkinson's disease: from basic research to clinical correlates. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 110: 2006-13. PMID 10616104 DOI: 10.1016/S1388-2457(99)00173-X |
0.348 |
|
| 1999 |
Centonze D, Gubellini P, Bernardi G, Calabresi P. Permissive role of interneurons in corticostriatal synaptic plasticity. Brain Research. Brain Research Reviews. 31: 1-5. PMID 10611492 DOI: 10.1016/S0165-0173(99)00018-1 |
0.374 |
|
| 1999 |
Centonze D, Gubellini P, Picconi B, Calabresi P, Giacomini P, Bernardi G. Unilateral dopamine denervation blocks corticostriatal LTP. Journal of Neurophysiology. 82: 3575-9. PMID 10601483 DOI: 10.1152/Jn.1999.82.6.3575 |
0.361 |
|
| 1999 |
Napolitano M, Marfia GA, Vacca A, Centonze D, Bellavia D, Di Marcotullio L, Frati L, Bernardi G, Gulino A, Calabresi P. Modulation of gene expression following long-term synaptic depression in the striatum. Brain Research. Molecular Brain Research. 72: 89-96. PMID 10521602 DOI: 10.1016/S0169-328X(99)00213-2 |
0.309 |
|
| 1999 |
Calabresi P, Centonze D, Pisani A, Bernardi G. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Experimental Neurology. 158: 97-108. PMID 10448421 DOI: 10.1006/Exnr.1999.7092 |
0.378 |
|
| 1999 |
Calabresi P, Centonze D, Gubellini P, Bernardi G. Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology. 38: 323-6. PMID 10218876 DOI: 10.1016/S0028-3908(98)00199-3 |
0.328 |
|
| 1999 |
Calabresi P, Centonze D, Marfia GA, Pisani A, Bernardi G. An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. British Journal of Pharmacology. 126: 689-96. PMID 10188980 DOI: 10.1038/Sj.Bjp.0702361 |
0.371 |
|
| 1999 |
Calabresi P, Centonze D, Gubellini P, Marfia GA, Bernardi G. Glutamate-triggered events inducing corticostriatal long-term depression. The Journal of Neuroscience. 19: 6102-6110. DOI: 10.1523/Jneurosci.19-14-06102.1999 |
0.388 |
|
| 1999 |
Calabresi P, Gubellini P, Centonze D, Sancesario G, Morello M, Giorgi M, Pisani A, Bernardi G. A Critical Role of the Nitric Oxide/cGMP Pathway in Corticostriatal Long-Term Depression The Journal of Neuroscience. 19: 2489-2499. DOI: 10.1523/Jneurosci.19-07-02489.1999 |
0.332 |
|
| 1998 |
Centonze D, Calabresi P, Pisani A, Marinelli S, Marfia GA, Bernardi G. Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons. Neuropharmacology. 37: 1063-70. PMID 9833635 DOI: 10.1016/S0028-3908(98)00081-1 |
0.353 |
|
| 1998 |
Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. The European Journal of Neuroscience. 10: 3020-3. PMID 9758172 DOI: 10.1111/J.1460-9568.1998.00348.X |
0.369 |
|
| 1998 |
Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. The European Journal of Neuroscience. 10: 2887-95. PMID 9758158 DOI: 10.1111/J.1460-9568.1998.00294.X |
0.347 |
|
| 1998 |
Calabresi P, Centonze D, Pisani A, Sancesario G, North RA, Bernardi G. Muscarinic IPSPs in rat striatal cholinergic interneurones. The Journal of Physiology. 510: 421-7. PMID 9705993 DOI: 10.1111/J.1469-7793.1998.421Bk.X |
0.329 |
|
| 1998 |
Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Annals of Neurology. 43: 586-97. PMID 9585352 DOI: 10.1002/Ana.410430506 |
0.362 |
|
| 1997 |
Calabresi P, Centonze D, Pisani A, Bernardi G. A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 1121-6. PMID 9346437 DOI: 10.1097/00004647-199710000-00014 |
0.328 |
|
| 1997 |
Pisani A, Calabresi P, Centonze D, Bernardi G. Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse. Neuropharmacology. 36: 845-51. PMID 9225312 DOI: 10.1016/S0028-3908(96)00177-3 |
0.327 |
|
| 1997 |
Calabresi P, Pisani A, Centonze D, Bernardi G. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neuroscience and Biobehavioral Reviews. 21: 519-23. PMID 9195611 DOI: 10.1016/S0149-7634(96)00029-2 |
0.357 |
|
| 1997 |
Pisani A, Calabresi P, Centonze D, Bernardi G. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. British Journal of Pharmacology. 120: 1007-14. PMID 9134210 DOI: 10.1038/Sj.Bjp.0700999 |
0.318 |
|
| 1997 |
Calabresi P, Saiardi A, Pisani A, Baik JH, Centonze D, Mercuri NB, Bernardi G, Borrelli E. Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors The Journal of Neuroscience. 17: 4536-4544. DOI: 10.1523/Jneurosci.17-12-04536.1997 |
0.384 |
|
| 1997 |
Calabresi P, Centonze D, Pisani A, Bernardi G. Endogenous Adenosine Mediates the Presynaptic Inhibition Induced by Aglycemia at Corticostriatal Synapses The Journal of Neuroscience. 17: 4509-4516. DOI: 10.1523/Jneurosci.17-12-04509.1997 |
0.368 |
|
| 1997 |
Calabresi P, Ascone CM, Centonze D, Pisani A, Sancesario G, D’Angelo V, Bernardi G. Opposite Membrane Potential Changes Induced by Glucose Deprivation in Striatal Spiny Neurons and in Large Aspiny Interneurons The Journal of Neuroscience. 17: 1940-1949. DOI: 10.1523/Jneurosci.17-06-01940.1997 |
0.306 |
|
| 1996 |
Calabresi P, Pisani A, Centonze D, Stefani A, Bernardi G, Lucia OS. Role of mGluRs in the modulation of synaptic activity of different striatal neuronal subtypes Neuropharmacology. 35: A7. DOI: 10.1016/0028-3908(96)84675-2 |
0.346 |
|
| 1996 |
Calabresi P, Pisani A, Centonze D, Bernardi G. Role of Ca2+in striatal LTD and LTP Seminars in Neuroscience. 8: 321-328. DOI: 10.1006/Smns.1996.0039 |
0.334 |
|
| Show low-probability matches. |